Sean Williams, Motley Fool author won't tell you but I will:
Syndros is looking like a major whiff
Syndros is a liquid analog of a fully legal decades-long FDA-approved synthetic pure THC drug branded Marinol [generic name: dronabinol].
There has never been a legal banning of Marinol as marijuana or "pot" - the name favored by Mr. Williams - but Insys' liquified and aerosolized version of dronabinol carries the the handicap of a Class II addictive drug, which it isn't. The patented delivery of carefully titred patented delivery system offers very fast relief directly into the bloodstream through the mouth but there is no relief for Syndros from the false claims of the FDA. INSY even had to struggle to avoid the Class I label of an addictive drug without any medical value.
How many doctors and patients are going to be willing to go to the extra trouble for a lie every well-educated person knows is false?
Will INSY be destroyed while the real culprits in the drug wars escape?
Could be.
I am betting INSY will survive and thrive but I have no good defense against someone calling me a damn fool instead of a Motely Fool.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.